AG-13958AG-13958
Move your mouse over image or click to enlarge

AG-13958

AG-13958 (AG-013958), a VEGFR tyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD).
Cat# Size Price Qty Buy
S2211-5mg 5mg
£349.00
S2211-2mg 2mg
£177.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# S2211

Related Documents